CAR-NK therapy: an effective strategy for cancer treatment

Written by Sino Biological
Cancer research Drug discovery and development Immunology

CAR-NK therapy involves the modification of natural killer (NK) cells with mature chimeric antigen receptor (CAR) technology to exploit their unique target cell recognition mechanism and broad tumor-killing ability.

In this Application Note, experts from Sino Biological introduce the CAR-NK therapeutic strategy, which has numerous advantages to enhance overall safety and reduce antigenic escape failure.

CAR-NK Therapy-An Effective Strategy for Cancer Treatment

This content was provided by

Follow Sino Biological on Twitter, Facebook and on LinkedIn.